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Continuous glucose monitoring (CGM) devices have been used in newborn infants to detect hypoglycemia, which is thought to cause negative long-term developmental outcomes. Several studies report that CGM detects hypoglycemia at a higher rate than intermittent blood glucose (BG) measurements, but CGM data is typically not available for at least 1 hour after sensor insertion. This study compares hypoglycemia detection via intermittent BG monitoring and CGM in neonates. 

Method: 
CGM and BG data from 161 at-risk infants were used to investigate hypoglycemia (BG < 47mg/dL). All BG measurements were determined using a blood gas analyzer (BGA – Radiometer ABL800FLEX) and CGM (Medtronic CGMS Gold) sensors were inserted as soon as was practical after birth. A previously published recalibration algorithm was applied to CGM data before median filtering. The incidence of hypoglycemia detected by BG and CGM was compared.  

Result: 
Of the 2271 BG measurements recorded 399 detected hypoglycemia and 198 of these occurred during CGM. However, CGM reported 337 hypoglycemic episodes, suggesting that 139 episodes were missed and occurred between intermittent BG measurements. Conversely, during the first 6 hours after birth, when hypoglycemia was most prevalent, a total of 213 episodes were detected by BG measurements and only 65 of these were detected by CGM due to the ~3 hour delay after birth before CGM data were available. After this 6 hour period, CGM consistently detected more episodes than intermittent BG monitoring. 

Conclusion: 
The results of this study showed that hypoglycemia is most prevalent during the first 24 hours after birth in at-risk infants. Thus, an optimal measurement protocol for detecting the episodes might consist of CGM with regular intermittent BG measurements for the first 6 hours after birth.

